Autolus Therapeutics PLC experienced two insider transactions within the last ninety days, resulting in a net negative value of approximately 15,682 USD. U.S. CCO Cintia Piccina executed a sale of 6,713 shares on September 2, 2026. This activity follows a period where the stock price declined by 22.1 percent, preceding the upcoming November earnings report.